Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduction in urinary oxalate values by allopurinol

R Scott, P J Paterson, M Smith

    Urology
    |August 1, 1978
    PubMed
    Summary

    Allopurinol can help prevent kidney stone recurrence by reducing urinary oxalate levels, particularly in individuals with high blood urate levels. This study explores the drug's effectiveness and potential mechanisms in stone formers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    Canadian Surgery Forum.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    Canadian Surgery Forum.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    CNs 'must target women' in health drive.

    Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2016
    Same author

    Nurses need more expertise before undertaking research.

    Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2016
    Same author

    Nursing's new role in the future of research.

    Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2016

    Area of Science:

    • Nephrology
    • Urology
    • Pharmacology

    Background:

    • Kidney stone disease recurrence is a significant clinical challenge.
    • Various pharmacological agents are used to prevent stone recurrence.
    • Allopurinol has emerged as a potential therapeutic option for stone prevention.

    Purpose of the Study:

    • To investigate the effect of allopurinol on urinary oxalate excretion in patients with a history of kidney stones.
    • To identify patient subgroups that may benefit most from allopurinol therapy for stone prevention.

    Main Methods:

    • The study involved a group of stone formers.
    • Urinary oxalate levels were measured before and after allopurinol administration.
    • Blood urate levels were analyzed to correlate with treatment response.

    Main Results:

    • Allopurinol treatment led to a significant reduction in urinary oxalate.
    • The reduction in urinary oxalate was most pronounced in subjects with blood urate levels exceeding 300 µmol/L.
    • This suggests a dose-dependent or threshold effect of allopurinol related to baseline hyperuricemia.

    Conclusions:

    • Allopurinol effectively reduces urinary oxalate in stone formers, indicating a role in preventing stone recurrence.
    • Patients with elevated blood urate levels may experience greater benefit from allopurinol therapy.
    • Further research into the mechanisms of action is warranted to optimize its use in stone disease management.

    Related Experiment Videos